PhaseRx Inc. (PZRX) Leaped To Almost A 2-Month High On FDA News
PhaseRx Inc. (PZRX) announced Monday morning that the FDA has granted orphan drug status to its PRX-OTC, for the treatment of ornithine transcarbamylase deficiency.
from RTT - Before the Bell http://ift.tt/2geYqKj
via IFTTT
No comments:
Post a Comment